Don’t let the high cost of brand absence seizure therapy disrupt your treatment. We help eligible patients access Zarontin (ethosuximide) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
Zarontin PAP for absence epilepsy patients uninsured/underinsured.
Eligibility, neurology coordination, prior-auth.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$680 | Save ~$610/mo |
| CVS Pharmacy (brand) | ~$700 | Save ~$630/mo |
| Walmart (brand) | ~$450 | Save ~$380/mo |
| Costco (brand) | ~$430 | Save ~$360/mo |
Generic ethosuximide | ~$60 | Generic low |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
PAP at no cost if approved. With generic ethosuximide widely available, generic is usually the cheaper path.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Zarontin:
Still $400–$700 per month even with the best discount
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Zarontin assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Zarontin (ethosuximide) is a succinimide antiepileptic specifically effective for absence (petit mal) seizures. Absence seizures involve brief lapses of awareness with characteristic 3-Hz spike-wave discharges on EEG — distinct from other seizure types. Ethosuximide is one of the first-line therapies for childhood absence epilepsy.
How Zarontin Works:
Absence seizures arise from thalamocortical circuitry involving T-type calcium channels in thalamic neurons — generating the characteristic 3-Hz spike-wave rhythm. Blocking T-type calcium channels disrupts this oscillation.
Ethosuximide selectively blocks T-type calcium channels in thalamic neurons — reducing the thalamocortical synchronization that generates absence seizures. Ethosuximide is highly selective for absence seizures — does not work for other seizure types and may worsen generalized tonic-clonic seizures.
Form and use:
Zarontin available as capsules and oral solution. Pediatric starting dose 250 mg daily (oral solution 5 mL/day), titrated based on response. Adult doses typically 750–1500 mg/day in 2–3 divided doses. Take with food to reduce GI side effects.
Generic availability:
Generic ethosuximide capsules and oral solution widely available. For absence epilepsy first-line per Glauser et al pediatric trial (NEJM 2010): ethosuximide and valproic acid are similarly effective and superior to lamotrigine; ethosuximide has fewer attentional side effects than valproate.
Warnings:
Zarontin carries warnings for serious skin reactions (Stevens-Johnson syndrome rare), blood dyscrasias (rare — agranulocytosis, aplastic anemia, pancytopenia; periodic CBC), systemic lupus erythematosus (drug-induced), psychiatric/behavioral changes (sometimes induces psychotic symptoms or worsening of preexisting conditions), suicidal ideation (class effect of AEDs), and embryo-fetal toxicity.
Brand $400–$700/month. Generic ethosuximide $30–$100/month. Generic usually cheaper.
No. Ethosuximide is highly selective for absence seizures. Does not work for tonic-clonic, partial-onset, or other seizure types — and may worsen generalized tonic-clonic seizures. For patients with mixed seizure types, valproic acid is often preferred (effective for both absence and generalized tonic-clonic).
Per the landmark Glauser pediatric absence trial: both are similarly effective. Ethosuximide has fewer attentional side effects (less cognitive impairment than valproate). Valproate has broader spectrum (covers absence AND generalized tonic-clonic, mixed seizures). For absence-only, ethosuximide often preferred. For mixed seizures or absence with tonic-clonic, valproate may be better.
Few significant interactions. Carbamazepine, phenytoin, phenobarbital can lower ethosuximide levels. Valproate may modestly raise ethosuximide levels (sometimes intentional combination).
Limited safety data. Discuss with neurologist if pregnancy planned or occurs.
Yes, FDA-approved bioequivalent.
Switch to generic ethosuximide (much cheaper) or generic valproate for absence epilepsy. Manufacturer copay or Epilepsy Foundation may help.
If struggling with Zarontin cost, we can help — or guide you to generic ethosuximide. Check eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.